115 related articles for article (PubMed ID: 7508822)
1. Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.
Dilling MB; Dias P; Shapiro DN; Germain GS; Johnson RK; Houghton PJ
Cancer Res; 1994 Feb; 54(4):903-7. PubMed ID: 7508822
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
Hosoi H; Dilling MB; Shikata T; Liu LN; Shu L; Ashmun RA; Germain GS; Abraham RT; Houghton PJ
Cancer Res; 1999 Feb; 59(4):886-94. PubMed ID: 10029080
[TBL] [Abstract][Full Text] [Related]
3. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
Dumont FJ; Staruch MJ; Grammer T; Blenis J; Kastner CA; Rupprecht KM
Cell Immunol; 1995 Jun; 163(1):70-9. PubMed ID: 7538911
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists.
Hatfield SM; Mynderse JS; Roehm NW
J Pharmacol Exp Ther; 1992 Jun; 261(3):970-6. PubMed ID: 1376361
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
Dumont FJ; Kastner C; Iacovone F; Fischer PA
J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
Crouch GD; Helman LJ
Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
[TBL] [Abstract][Full Text] [Related]
7. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of rapamycin (Sirolimus, Rapamune).
Molnar-Kimber KL
Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
[No Abstract] [Full Text] [Related]
9. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
Dumont FJ; Kastner CA
J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells.
Ishizuka T; Sakata N; Johnson GL; Gelfand EW; Terada N
Biochem Biophys Res Commun; 1997 Jan; 230(2):386-91. PubMed ID: 9016789
[TBL] [Abstract][Full Text] [Related]
11. Effects of rapamycin on hematopoiesis.
Quesniaux VF; Wehrli S; Wioland C; Schuler W; Schreier MH
Transplant Proc; 1994 Dec; 26(6):3135-40. PubMed ID: 7998093
[No Abstract] [Full Text] [Related]
12. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH
Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500
[TBL] [Abstract][Full Text] [Related]
13. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
Hultsch T; Hohman RJ
Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
[No Abstract] [Full Text] [Related]
14. Insulin-like growth factor binding protein-6 and CCI-779, an ester analogue of rapamycin, additively inhibit rhabdomyosarcoma growth.
Gallicchio MA; van Sinderen M; Bach LA
Horm Metab Res; 2003; 35(11-12):822-7. PubMed ID: 14710364
[TBL] [Abstract][Full Text] [Related]
15. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
Dumont FJ; Fischer P; Sirotina A
Exp Cell Res; 1995 Jul; 219(1):146-58. PubMed ID: 7543051
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
Bierer BE
Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
[No Abstract] [Full Text] [Related]
17. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.
Lee TC; Zhang Y; Aston C; Hintz R; Jagirdar J; Perle MA; Burt M; Rom WN
Cancer Res; 1993 Jun; 53(12):2858-64. PubMed ID: 7684950
[TBL] [Abstract][Full Text] [Related]
18. Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis.
Petak I; Douglas L; Tillman DM; Vernes R; Houghton JA
Clin Cancer Res; 2000 Oct; 6(10):4119-27. PubMed ID: 11051265
[TBL] [Abstract][Full Text] [Related]
19. In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.
Kalebic T; Tsokos M; Helman LJ
Cancer Res; 1994 Nov; 54(21):5531-4. PubMed ID: 7923191
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
Yee D; Jackson JG; Kozelsky TW; Figueroa JA
Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
